Empagliflozin impurity 255 CAS CATO-C4X-1065255

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.CATO-C4X-1065255
Molecular FormulaC6H10O6
Molecular Weight178.14 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Empagliflozin impurity 255 CAS CATO-C4X-1065255 chemical structure

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Empagliflozin impurity 255.

As a process- or degradation-related impurity, Empagliflozin impurity 255 (CAS CATO-C4X-1065255, C6H10O6) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.

Structurally, Empagliflozin impurity 255 (C6H10O6) contains a carbohydrate-derived structure. The molecule exhibits a degree of unsaturation (DBE) of 2.0, corresponding to approximately 2 ring(s) or double-bond equivalent(s). With a molecular weight of 178.14 g/mol, it falls into the medium-molecular-weight range.

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

CATO manufactures Empagliflozin impurity 255 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC6H10O6
Molecular Weight178.14 g/mol
Purity97%+
StorageStore at 2-8°C, keep sealed and dry
Solubility (reference)Soluble in methanol, ethanol, DMSO, water
StabilityHygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)2.0

Related Empagliflozin Standards

Recommended Standards

Why CATO?